Concomitant use of clopidogrel and proton-pump inhibitor: A reality check

Subhash Banerjee, Ahmad Zankar, Rick Weideman, Bertis Little, Emmanouil S. Brilakis

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


There are emerging reports supporting the fact that proton-pump inhibitors competitively inhibit the metabolism of clopidogrel to its active metabolite and diminish its clinical efficacy, especially in patients on long-term dual antiplatelet therapy. In this article, we examine the current evidence and provide interpretation of the results along with practical recommendations for healthcare providers.

Original languageEnglish (US)
Pages (from-to)121-125
Number of pages5
JournalInterventional Cardiology
Issue number2
StatePublished - Apr 2010


  • cardiovascular outcome
  • clopidogrel
  • proton-pump inhibitor

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Concomitant use of clopidogrel and proton-pump inhibitor: A reality check'. Together they form a unique fingerprint.

Cite this